Michael T. Steelman, D.o., Llc Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 136 Penn St, Hanover, PA 17331 Phone: 717-637-9219 Fax: 717-637-9715 |
Upmc Pinnacle Sheppard Wabco Firstline Care Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 507 E Middle St, Hanover, PA 17331 Phone: 717-634-5211 Fax: 717-646-7421 |
Oscar F Murillo, Md, Llc Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 250 Fame Ave, Suite 205b, Hanover, PA 17331 Phone: 717-632-1234 Fax: 717-632-2934 |
News Archive
In a feat of trickery, Dartmouth Medical School immunologists have devised a Trojan horse to help overcome ovarian cancer, unleashing a surprise killer in the surroundings of a hard-to-treat tumor.
Postmenopausal women, including those over 70 years old, who have been newly diagnosed with cancer in one breast have higher cancer detection rates when the other breast is scanned for tumors with MRI, compared to premenopausal women, say researchers at the Mayo Clinic campus in Florida.
According to a survey following Norwegian doctors over 20 years, nearly four out of ten doctors have been the target of threats from a patient during the first four years after graduation and one in seven doctors have been physically assaulted.
One classical question in developmental biology is how different tissue types arise in the correct position of the developing embryo. While one signaling pathway that controls this process has been well described, unexpected findings from a team led by Carnegie's Steven Farber reveal the importance of polyunsaturated fatty acid metabolism in this process. It is published online December 12 in Developmental Cell.
Heptares Therapeutics, the clinical-stage GPCR structure-guided drug discovery and development company, is delighted to announce that the Malcolm Campbell Memorial Prize for 2015 has been awarded to Miles Congreve (Vice President of Chemistry), Fiona Marshall (Chief Scientific Officer and co-founder) and Malcolm Weir (Chief Executive Officer and co-founder) for the seminal contributions to GPCR drug discovery made by Heptares Therapeutics since the company was founded in 2007.
› Verified 6 days ago